VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,381,880 | -33.6% | 758,355 | -22.2% | 3.50% | -26.6% |
| Q2 2023 | $15,642,641 | +101.9% | 975,227 | -2.7% | 4.76% | +120.3% |
| Q1 2023 | $7,747,447 | +42.7% | 1,002,257 | +256.3% | 2.16% | +28.9% |
| Q4 2022 | $5,428,260 | -9.4% | 281,257 | 0.0% | 1.68% | -12.7% |
| Q3 2022 | $5,994,000 | -97.9% | 281,257 | +7253.1% | 1.92% | -34.4% |
| Q2 2022 | $281,057,000 | +2320.2% | 3,825 | -98.0% | 2.93% | +12.0% |
| Q1 2022 | $11,613,000 | +263.1% | 190,749 | +58.3% | 2.62% | +267.8% |
| Q4 2021 | $3,198,000 | – | 120,535 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |